A Stiff joke In pharmacology all drugs have two names, a

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
189
A Stiff joke

In pharmacology all drugs have two names, a trade name and a generic name. For example, the trade name of Tylenol also has a generic name of Acetaminophen. Aleve is also called Naproxen. Amoxil is also called Amoxicillin and Advil has also been called Ibuprofen.
The FDA has been looking for a different name for Viagra. After a careful consideration by a government of experts, it has been recently announced that it has finally settled on a name of . . . Mycoxafloppin. Also considered were Mycoxafailin, Mycoxadrippin, Mycoxarisin, Dixafix, and of course, Ibepokin.

Pfizer Corp announced today that Viagra will soon be available in liquid form and will be marketed by Pepsi-Cola as a power beverage suitable for use as a mixer. It will now be possible for a man to legally pour himself a stiff one. Obviously we can no longer call this a soft drink, and it gives a new meaning to the names of "cocktails". and "highballs" and just a good old fashioned "stiff drink". Pepsi will market the new concoction by the name of Mount and do.

Thought for the day: there was, (and still is) more money being spent on breasts implants and Viagra than on Alzheimer's research. Which means we are nearing in on the age of where there will be an elderly population with perky boobs and huge erections and no recollection of what to do with them.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Brixton Metals Expands Thorn Project with New Mineral Claims

Updated Category News Views 198

Brixton Metals Expands Thorn Project with New Mineral Claims Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) has expanded its footprint at the Thorn Project, securing a 100% interest in mineral claims covering 6,446 hectares. These claims, which were previously outside Brixton’s control, sit northwest of the well-known Golden Bear Mine and add ground the company...

Continue Reading
Nutex Health Awaits Q2 Results Amid Regulatory Hurdles

Updated Category News Views 20

Diving headfirst into the grumbles of this healthcare whirlwind we call Nutex Health. They've set the table to drop their Q2 financials on August 6, right after the bell, followed by a chat with investors the next morning. We're talking bumper-to-bumper business news here, and everyone with a slice in NASDAQ: NUTX better have their ears pricked. Nutex Health: A Mixed Bag...

Continue Reading
Arvore Partners LP Announces Impressive October Distribution

Updated Category News Views 183

Arvore Partners LP Declares Monthly Distribution for October Arvore Partners LP is thrilled to share details about the declaration of its monthly distribution for October. This distribution amounts to $687,365, which translates to an impressive 9.06% annualized yield for its unitholders, marking a 7% increase from the previous month. This consistent growth highlights...

Continue Reading
Key Insights on Marathon Petroleum's Upcoming Earnings Call

Updated Category News Views 101

An Overview of Marathon Petroleum's Earnings Expectations Marathon Petroleum (NYSE: MPC) is gearing up for its quarterly earnings announcement. Investors should prepare for necessary insights leading up to the release of this important announcement. Analysts predict a solid earnings per share (EPS) of $3.23 for the upcoming quarter. While it’s crucial for the company to...

Continue Reading
Revolutionizing Male Infertility Research with PacBio's Revio

Updated Category News Views 80

Transforming Male Infertility Research with PacBio's Revio MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading name in sequencing solutions, is launching an exciting collaboration with the University Hospital of Münster. This partnership is set to leverage long-read whole genome sequencing to significantly advance research in male infertility and rare diseases....

Continue Reading